Solara Active Pharma Sciences Ltd (NSE:SOLARAPP1) Share Price

Company Profile

Business description
Solara Active Pharma Sciences Ltd is engaged in the Active Pharmaceutical Ingredients (API) in India. It manufactures and develops APIs and offers services, including CRAMS and contract manufacturing for APIs. The company offers products and services, such as Anaesthetic, Analgesics, Antiviral, Retinoid, Anti-emetic, Antimalarial, Diuretic, Muscle relaxant, Antiallergics, Antihypertensive, Calcimimetic agent, Anti-seizure, Antigout, Cardiovascular, Anti-infective, Cough suppressant, and others. It also offers contract services, including contract development and manufacturing, and analytical services. Geographically, the company generates all of its revenue from India.
Contact
Phase II - CSIR Road
Module No. 601, 602, 603, Ticel Bio Park
Taramani
ChennaiTN600113
IND
T: +91 4447406200
https://www.solara.co.in
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2027
Employees
2,924

Recommended

From AI integration to capital expenditure increases, here’s what we expect in Alphabet’s earnings report.

Malik Ahmed Khan, CFA | 24 April 2026

Santos reports a solid quarter on the back of higher commodity prices - yet the shares look undervalued.

Mark Taylor | 24 April 2026

ChatGPT and large language models should be a tailwind for this company.

Simonelle Mody | 24 April 2026

Index	Last price	Change	% Change
All Ordinaries	8,990.80	20.60	0.23%
CAC 40	8,145.33	12.49	-0.15%
DAX 40	24,148.40	19.42	0.08%
Dow JONES (US)	49,230.71	79.61	-0.16%
FTSE 100	10,348.77	30.31	-0.29%
HKSE	25,925.65	52.42	-0.20%
NASDAQ	24,836.60	398.10	1.63%
Nikkei 225	60,537.36	821.18	1.38%
NZX 50 Index	12,874.94	9.99	-0.08%
S&P 500	7,165.08	56.68	0.80%
S&P/ASX 200	8,766.40	17.20	0.20%
SSE Composite Index	4,086.34	6.44	0.16%